Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03846310
Title A Study to Evaluate Immunotherapy Combinations in Participants With Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arcus Biosciences, Inc.

lung non-small cell carcinoma


AB928 + Carboplatin + Pemetrexed Disodium


AB928 + Carboplatin + Pembrolizumab + Pemetrexed Disodium

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.